18F-FDG PET/CT Versus 18F-FAPI PET/CT in a Case of Recurrent Malignant Phyllodes Breast Tumor-Reference-Cited by-同舟云学术

18F-FDG PET/CT Versus 18F-FAPI PET/CT in a Case of Recurrent Malignant Phyllodes Breast Tumor

Published:2023-11-10 Issue:1 Volume:49 Page:e35-e37
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Jiang Shuqin¹,Jiang Ming²,Rao Songquan¹,Liang Jiucen¹,Zhang Rusen¹

Affiliation:

1. Nuclear Medicine

2. Breast Surgery, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.

Abstract

Abstract A 52-year-old woman with medical history of surgery for left malignant phyllodes breast tumor found a mass on the left chest 3 months ago. A suspicion of recurrent malignant phyllodes breast tumor was made. The patient was enrolled in the clinical trial of 18F-FAPI PET/CT in recurrent sarcoma (no. NCT05485792). 18F-FAPI PET/CT and 18F-FDG PET/CT were performed, and the images demonstrated intense uptake in a huge mass in the left anterior chest wall. Then the patient underwent extended resection of left chest wall tumor. The tumor proved to be recurrent malignant phyllodes breast tumor pathologically.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference9 articles.

1. 68Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer;J Nucl Med,2019

2. [18F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [68Ga]Ga-FAPI-04;Eur J Nucl Med Mol Imaging,2022

3. Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT;Eur J Nucl Med Mol Imaging,2021

4. Head-to-head evaluation of [18F]FDG and [68Ga]Ga-DOTA-FAPI-04 PET/CT in recurrent soft tissue sarcoma;Eur J Nucl Med Mol Imaging,2022

5. 68Ga-FAPI as a diagnostic tool in sarcoma: data from the 68Ga-FAPI PET prospective observational trial;J Nucl Med,2022